Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin crossover trial in children with Prader-Willi syndrome
NL-OMON44462Phase 2Active, not recruiting
- Sponsor
- Dutch Growth Research Foundation
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin in Prader-Willi syndrome (PWS) (2 arms), sponsored by Dutch Growth Research Foundation. Primary endpoint: Change in social behavior. Started May 2018; status: active, not recruiting.
02
Drugs
oxytocin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NL-OMON44462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44462.